Gerresheimer is a speciality glass and plastics manufacturer for applications in the pharmaceutical packaging industry.
12 Jun 2019
11 Mar 2019
Data sharing specialist Nallian said that it will launch the Global Pharma Tracker, the world's first data sharing platform for end-to-end tracking and monitoring of temperature-controlled pharma shipments, at the IATA World Cargo Symposium in Singapore.
07 Feb 2019
PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, has announced the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL.
22 Jan 2019
PCI Pharma Services (PCI) has announced further investment in its expansive infrastructure for packaging of controlled substances, complementing its capacity for blister packaging, a key tenet of recent calls for dispensing opioid prescriptions in limited quantity unit dose packaging as a tactic to combat substance misuse.
21 Jan 2019
Swiss drugmaker Novartis has selected Kinaxis’ RapidResponse platform as its new supply chain planning system to accelerate technical operation transformation.
17 Jan 2019
Schott, a Germany-based manufacturer of glass and glass-ceramics, has announced an investment of €300m in the coming three years in its pharmaceutical packaging business.
08 Jan 2019
PCI Pharma Services (PCI) will invest over $20m to expand its biotech technologies, including advanced injectable delivery forms, at multiple locations across the world, to meet demand for biotech packaging.
20 Dec 2018
Kuehne + Nagel has opened a new pharma and healthcare warehouse to expand its standardised GxP compliant offering for the pharma and healthcare industry.
11 Dec 2018
PCI Pharma Services (PCI) has announced an expansion of its onsite cold chain storage capabilities at its Hay-on-Wye facility in the UK.
10 Dec 2018
French pharmaceutical company Cristers has selected Adents Prodigi cloud serialisation solution to ensure compliance with the EU Falsified Medicines Directive (FMD) and provide beyond-compliance ROI.